Resultados da busca por Autor

1

$Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates por Evan C. Chen (15054014)

Publicado em 2025
Outros Autores:

Salvar na lista

Na minha lista:
2

$Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates por Evan C. Chen (15054014)

Publicado em 2025
Outros Autores:

Salvar na lista

Na minha lista:
3

$Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates por Evan C. Chen (15054014)

Publicado em 2025
Outros Autores:

Salvar na lista

Na minha lista:
4

$Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates por Evan C. Chen (15054014)

Publicado em 2025
Outros Autores:

Salvar na lista

Na minha lista:
5

$Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates por Evan C. Chen (15054014)

Publicado em 2025
Outros Autores:

Salvar na lista

Na minha lista:
6

$Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates por Evan C. Chen (15054014)

Publicado em 2025
Outros Autores:

Salvar na lista

Na minha lista:
7

Supplementary Table S3 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Publicado em 2025
Outros Autores:

Salvar na lista

Na minha lista:
8

Supplementary Table S8 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Publicado em 2025
Outros Autores:

Salvar na lista

Na minha lista:
9

Supplementary Table S4 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Publicado em 2025
Outros Autores:

Salvar na lista

Na minha lista:
10

Supplementary Table S5 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Publicado em 2025
Outros Autores:

Salvar na lista

Na minha lista:
11

Supplementary Table S2 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Publicado em 2025
Outros Autores:

Salvar na lista

Na minha lista:
12

Supplementary Table S6 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Publicado em 2025
Outros Autores:

Salvar na lista

Na minha lista:
13

Supplementary Table S7 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Publicado em 2025
Outros Autores:

Salvar na lista

Na minha lista:
14

Supplementary Table S9 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Publicado em 2025
Outros Autores:

Salvar na lista

Na minha lista:
15

Supplementary Table S1 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Publicado em 2025
Outros Autores:

Salvar na lista

Na minha lista:

Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates por Evan C. Chen (15054014)

Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates por Evan C. Chen (15054014)

Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates por Evan C. Chen (15054014)

Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates por Evan C. Chen (15054014)

Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates por Evan C. Chen (15054014)

Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates por Evan C. Chen (15054014)

Supplementary Table S3 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Supplementary Table S8 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Supplementary Table S4 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Supplementary Table S5 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Supplementary Table S2 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Supplementary Table S6 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Supplementary Table S7 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Supplementary Table S9 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Supplementary Table S1 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States por Laura E. Stevens (14961009)

Ferramentas de busca: